Free Trial

Ionis Pharmaceuticals (IONS) SEC Filings & 10K Form

Ionis Pharmaceuticals logo
$42.62 -0.13 (-0.30%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$42.32 -0.30 (-0.70%)
As of 09:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Ionis Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/26/2025
4:23 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2025
1:01 PM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2025
5:14 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025
9:34 AM
Ionis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
08/08/2025
5:55 PM
Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
5:44 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
4:28 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2025
3:53 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2025
2:56 PM
Ionis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2025
10:16 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
3:54 PM
HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
3:54 PM
Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
3:54 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
3:54 PM
Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
3:59 PM
Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
7:54 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
8:00 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
5:02 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025
6:18 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
3:26 PM
Ionis Pharmaceuticals (Filer)
Form DEFA14A
04/25/2025
3:27 PM
Ionis Pharmaceuticals (Filer)
Form ARS
04/17/2025
3:53 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
3:53 PM
Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
3:53 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
8:35 AM
BlackRock, Inc. (Filed by)
Ionis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/16/2025
4:38 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2025
4:40 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2025
4:41 PM
Ionis Pharmaceuticals (Subject)
Jenne Kyle (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
3:45 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:17 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:06 PM
Ionis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2025
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
3:53 PM
Capital World Investors (Filed by)
Ionis Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/07/2025
10:55 AM
Ionis Pharmaceuticals (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G/A
02/06/2025
5:26 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad)

With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel

Claim your free copy of “How to Survive the Next Financial Crisis” today
02/06/2025
5:27 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:26 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
4:43 PM
Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:41 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:01 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:02 PM
Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:03 PM
Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:58 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:59 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:40 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM
Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
6:31 PM
Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:18 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:19 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:21 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:22 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:23 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:25 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:28 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:29 PM
Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:30 PM
Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
10:29 AM
Ionis Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/06/2025
3:52 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:52 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:52 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:52 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:57 PM
Hayden Michael R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
1:28 PM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:34 PM
BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
7:55 AM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
11/08/2024
9:52 AM
Ionis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/06/2024
3:06 PM
Ionis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad)

With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel

Claim your free copy of “How to Survive the Next Financial Crisis” today
10/17/2024
5:39 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
5:42 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
5:01 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
5:01 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:19 PM
Ionis Pharmaceuticals (Filer)
Form 424B5
09/09/2024
3:33 PM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:23 PM
Ionis Pharmaceuticals (Filer)
Form 424B5
09/04/2024
8:43 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:43 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IONS) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners